Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Moderate Alcohol Intake Linked with Stronger Bones

By LabMedica International staff writers
Posted on 22 Apr 2009
Drinking moderate amounts of alcohol has been found to be associated with greater bone mineral density in men and women mostly over age 60, according to a new study. More...


Researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University (Medford, MA, USA) found a positive association between beer and wine and greater bone density, but at the same time noted that bone mineral density was significantly lower in men drinking more than two servings of liquor per day.

The findings suggest that regular moderate consumption of beer or wine may have protective effects on bone, but that heavy drinking may contribute to bone loss. "Previous research suggests that moderate alcohol consumption in older men and postmenopausal women may protect against bone mineral density loss, a major risk factor for osteoporosis," said Dr. Katherine Tucker, director of the Dietary Assessment and Epidemiology Research Program at the HNRCA. The 2005 dietary guidelines issued by the U.S. federal government define moderate alcohol consumption as one drink a day for women and two drinks daily for men.

"Our study also looks at the possible effects of the three alcohol classes, beer, wine, and liquor, on bone mineral density," stated Dr. Tucker, who is also a professor at the Tufts Friedman School of Nutrition Science and Policy. "We saw stronger associations between higher bone mineral density and beer drinkers, who were mostly men, and wine drinkers, who were mostly women, compared to liquor drinkers."

The results were published in the March 2009 issue of the American Journal of Clinical Nutrition. Dr. Tucker, who is also an adjunct associate professor of family medicine and community health at Tufts Medical School, and her colleagues analyzed bone mineral density measurements taken at three hip sites and the lumbar spine in 1,182 men, 1,289 postmenopausal women, and 248 premenopausal women whose parents or in-laws participated in the original Framingham Heart Study.

There was not enough data to determine the effects of more than two servings of alcohol per day in postmenopausal women or the effects of daily alcohol consumption on bone mineral density in premenopausal women. Participants self-reported their alcohol intake on dietary questionnaires: one serving of beer equaled a glass, bottle, or can. One serving of wine equaled 118 ml, and one serving of liquor equaled one mixed drink or shot.

After adjusting for other factors that may have accounted for the higher bone mineral density, such as silicon intake, calcium intake, and smoking history, the investigators noted an association between higher bone mineral density and moderate alcohol consumption. One of the strongest associations was seen in men who reported consuming one or two servings of total alcohol (a combination of beer, wine, and liquor) or one or two servings of beer per day. Hipbone mineral density in this group was significantly greater compared to nondrinkers.

In contrast, the investigators observed considerably lower bone mineral density at the hip and spine in men who consumed more than two servings of liquor per day compared to men who consumed one or two servings of liquor per day. "There is a body of research showing alcoholism is devastating to bones," Dr. Tucker noted. "It's a major risk factor for osteoporosis. No one should depend solely on alcohol to maintain bone health."

The researchers hypothesized that the silicon in beer contributed to the higher bone mineral density scores in the men who reported consuming one or two servings of total alcohol or beer per day. Earlier research had found that silicon has greater bioavailability as a liquid. It is less apparent why liquor and wine might protect bone mineral density.

"We cannot say definitively what component of these alcoholic drinks might be beneficial to bone health, because our findings are from an observational study as opposed to a clinical trial," Dr. Tucker said. "Future studies might dig deeper into patterns of alcohol consumption, as we relied on a self-reported dietary questionnaire. Another component of data worthy of exploration is whether the antioxidants found in wine, such as revesterol or polyphenols, have a protective effect on bone in addition to other health benefits."

Related Links:
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.